Published in Vaccine Weekly, October 29th, 2003
The award was made under the NIAID's HIV Vaccine Design and Development Teams (HVDDT) program whose goal is to fund development of promising vaccine concepts with plans for targeted testing in humans. Epimmune will lead a consortium that will include Bavarian Nordic A/S...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly